Your T-Bill Ladder Has a New Ally
Bessent’s Treasury twist and the GENIUS Act are reshaping the short end. Here is what cash holders should know.
Bessent’s Treasury twist and the GENIUS Act are reshaping the short end. Here is what cash holders should know.
September 29 brings 100% Section 232 duties on patented drugs and APIs for importers without an onshoring plan or MFN…